Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Biomarker Pilot Trial of Fluvastatin Use in Women With Ductal Carcinoma in Situ (DCIS) or Stage I Breast Cancer

NCT00416403 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00416403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00416403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Biomarker Pilot Trial of Fluvastatin Use in Women With Ductal Carcinoma in Situ (DCIS) or Stage I Breast Cancer
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2006
Completion date
June 30, 2011
Enrollment
35 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer